Science & HealthUnverifiedGathered automatically from the outlets below; our newsroom hasn't checked it yet. Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal Oct 23, 8:15 AM RReuters Read the original at reuters.com ↗